Ingevity (NGVT) urged shareholders to vote in favor of all of its board nominees Thursday in a letter accompanying its definitive proxy statement ahead of its annual meeting on April 30, where a proxy fight may take place with activist investor Vision One Fund.
The company said it has made "meaningful efforts to reach a constructive resolution and avoid a proxy fight" with Vision One, which it said is seeking the election of two nominees.
The South Carolina specialty chemicals company said the activist investor's two nominees have never served as company directors or senior executives of a publicly-traded firm and have no industry experience.
Vision One did not immediately reply to MT Newswires' request for comment.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。